Similar Articles
Transition readiness in adolescents with juvenile idiopathic arthritis and their parents: Our single-center experience
Dragana Lazarević, Stefan Đorđević, Dušica Novaković, Maja Zečević, Gordana Sušić
DOI: 10.46497/ArchRheumatol.2022.9219
Efficacy of anakinra treatment in pediatric rheumatic diseases: Our single-center experience
Ferhat Demir, Eda Gürler, Betül Sözeri
DOI: 10.46497/ArchRheumatol.2022.8998
The reliability of Juvenile Arthritis Magnetic Resonance Imaging Scoring system in the evaluation of the shoulder joint in juvenile idiopathic arthritis
Murugan Sudhakar, Shivani Deswal, Namrita Sachdev, Somdipa Pal, Tribhuvan Pal Yadav
DOI: 10.46497/ArchRheumatol.2022.9304
Pericardial effusion in children admitted with juvenile idiopathic arthritis: A multicenter retrospective cohort study from the pediatric health information system
Daniel Fiedorek, Xinyu Tang, Sukesh Sukumaran, R. Thomas Collins, Elijah Bolin
DOI: 10.46497/ArchRheumatol.2023.9690
Analysis of treatment outcomes in patients with antineutrophil cytoplasmic antibody-associated vasculitis on rituximab therapy
Tsvetelina Yoneva, Yana Zdravkova, Georgi Kotov, Ekaterina Ivanova Todorova, Georgi Vasilev, Rasho Rashkov, Ivan Sheytanov
DOI: 10.46497/ArchRheumatol.2023.9556
Risk of flare in juvenile idiopathic arthritis: Is it related to the methotrexate treatment strategy or patient characteristics?
Rana İşgüder, Zehra Kızıldağ, Rüya Torun, Tuncay Aydın, Balahan Makay, Erbil Ünsal
DOI: 10.46497/ArchRheumatol.2023.10035
Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis
Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria
DOI: 10.46497/ArchRheumatol.2024.10199